Nec-1 compound,
necrostatin-1,
Necrostatin-1,
4311-88-0,
MTH-DL-Tryptophan,
Necrostatin 1,
Nec-1,
5-(1H-indol-3-ylmethyl)-3-methyl-2-thioxo-4-Imidazolidinone,
MTH-trp,
methyl-thiohydantoin-tryptophan,
Necroptotic Inhibitor, Nec-1,
5-((1H-indol-3-yl)methyl)-3-methyl-2-thioxoimidazolidin-4-one,
MFCD00056916,
AK326153,
4-imidazolidinone, 5-(1H-indol-3-ylmethyl)-3-methyl-2-thioxo-,
5-(1H-indol-3-ylmethyl)-3-methyl-2-sulfanylideneimidazolidin-4-one,
5-(indol-3-ylmethyl)-3-methyl-2-thio-Hydantoin,
5-(Indol-3-ylmethyl)-(2-thio-3-methyl)hydantoin,
Methylthiohydantoin-DL-tryptophan;MTH-DL-tryptophan,
Iflab-Bb F0911-6127,
5-(1H-Indol-3-ylmethyl)-3-methyl-2-thioxoimidazolidin-4-one,
4-Imidazolidinone,5-(1H-indol-3-ylmethyl)-3-methyl-2-thioxo-,
NECROSTATIN,
CID2828334,
AC1MCZ8E,
Oprea1_645908,
CBDivE_006695,
MLS006011643,
SCHEMBL856922,
CHEMBL195008,
GTPL9750,
methylthiohydantoin-DL-tryptophan,
BDBM36371,
CHEBI:91658,
CTK8G1778,
BIM0213,
DTXSID40385186,
ZX-AFC000637,
HMS3229H21,
HMS3268N04,
HMS3653J04,
HMS3677G04,
AOB31737,
BCP06760,
EX-A2108,
ZX-AV000803,
Necrostatin-1, >=98% (HPLC),
2581AH,
BN0375,
GL2538,
IN1207,
s8037,
STL452869,
STL511330,
AKOS001662677,
AKOS016050497,
AKOS023092523,
CS-1666,
MCULE-8919668366,
KS-0000184H,
NCGC00092372-01,
NCGC00092372-02,
NCGC00092372-03,
4CA-0898,
AS-10165,
BC600441,
HY-15760,
SC-94539,
SMR001375661,
FT-0635218,
SW219795-1,
EC-000.2418,
S-7747,
AB00073999-01,
A826160,
C-16170,
BRD-A36318220-001-01-3,
Hydantoin, 5-(indol-3-ylmethyl)-3-methyl-2-thio- (7CI,8CI),
5-(1H-indol-3-ylmethyl)-3-methyl-2-sulfanylidene-4-imidazolidinone,
4-Imidazolidinone, 5-(1H-indol-3-ylmethyl)-3-methyl-2-thioxo- (9CI),
5-(1H-indol-3-ylmethyl)-3-methyl-2-sulfanylidene-imidazolidin-4-one,
5-(1H-indol-3-ylmethyl)-3-methyl-2-thioxo-4-Imidazolidinone, Nec-1,
5-(1H-indol-3-ylmethyl)-3-methyl-2-sulfanyl-3,5-dihydro-4H-imidazol-4-one,
Kartogenin,
Nec-1 compound,
C13H13N3OS,
Necrostatin-1, 98% - 10MG 10mg,
C507699,
4727-31-5,